FDA Targets Blood-Zapping Devices in Cancer Fight
Published Date: 3/18/2026
Proposed Rule
Summary
The FDA is planning to require companies that make blood irradiators used during cancer surgeries to get special approval before selling them. This change helps make sure these devices are safe and effective in preventing cancer spread. If finalized, manufacturers will have about 30 months to submit their approval applications, so they should get ready soon!
Analyzed Economic Effects
4 provisions identified: 0 benefits, 3 costs, 1 mixed.
PMA requirement for blood irradiators
If finalized, manufacturers of blood irradiators used to irradiate intraoperatively salvaged blood to help prevent metastasis must file a premarket approval (PMA). The PMA must be filed by the last day of the 30th calendar month after the device is classified into class III.
Market removal and investigational use rules
If a PMA is not timely filed, the device could be deemed adulterated and subject to enforcement, and manufacturers must stop distribution if a PMA is denied. Devices may only be distributed for investigational use under an approved investigational device exemption (IDE).
PMA must include clinical evidence and testing
FDA requires a PMA to include valid scientific evidence, full preclinical and clinical reports, and performance testing showing reasonable assurance of safety and effectiveness. FDA also encourages early meetings via the Q-Submission Program and recommends submitting an IDE at least 30 days before the PMA filing date to avoid interrupting investigations.
Short review window, continued marketing if timely filed
FDA says it intends to review any PMA for these devices within 180 days. A device that was in commercial distribution before May 28, 1976 (or found substantially equivalent by that date) may remain on the market during FDA's PMA review if a PMA is filed on time.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767 — Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He ignored the chance to defend himself, so the ban started on May 15, 2026. This means no drug imports from him for a while, but he can apply to end the ban anytime if he meets FDA’s conditions.
2026-09448 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3
The FDA is asking for approval to collect info for the third group in its Real Cost Campaign, which teaches kids about the dangers of tobacco. This helps the FDA improve its anti-smoking messages and protect young people’s health. Comments on this info collection are open until June 12, 2026, with no new costs for participants.
2026-09543 — Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This affects drug makers and healthcare folks who keep track of side effects. They’re asking for comments by July 13, 2026, to help improve the process without adding extra costs or paperwork.
2026-09544 — Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If approved, the renewal keeps these products on the market with their modified risk status, affecting smokers and the tobacco industry starting May 13, 2026.
2026-09335 — Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection
Hey there! This update is all about a new medical device that helps doctors quickly find germs and their resistance traits in people who might have bone infections. It affects hospitals and labs by officially classifying this device, making it easier and faster to diagnose tough infections. The change kicks in soon, helping patients get the right treatment without delay—and it could save money by avoiding wrong meds!
2026-09368 — Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability
The FDA is setting clear rules for certain new tobacco products like e-cigarettes and nicotine pouches that don’t have official approval yet. Companies selling these products without permission might face enforcement actions starting now, so they need to get authorized or risk penalties. This helps protect public health and keeps the market fair and safe.
Previous / Next Documents
Previous: 2026-05320 — Medical Devices; Radiology Devices; Classification of Blood Irradiators
The FDA is proposing new rules to make blood irradiators safer and more reliable. Devices that stop a serious transfusion problem will need a simpler review, while those aimed at preventing cancer spread will face a tougher approval process. If you make or use these devices, get ready to comment by May 18, 2026, and expect some extra costs for the stricter reviews.
Next: 2026-05327 — Airworthiness Directives; The Boeing Company Airplanes
If you fly or fix Boeing 787 planes, listen up! The FAA wants to update safety rules by swapping out a part on the wing’s leading edge to keep flights safer and add new maintenance checks. These changes keep all the old safety steps but add new ones, and comments are open until May 4, 2026—so there’s time to weigh in before any costs or work changes kick in.